Dupilumab Restores Growth in Children With Severe Atopic Dermatitis

New research highlights how effective treatment with dupilumab can address growth restriction in children with severe eczema.

Nov 25, 2024

∙ Paid

An illustration showing a pediatric growth chart with an upward trajectory, symbolizing improved growth in children. The image features a child standing confidently beside the chart, with clear skin and a happy demeanor, representing recovery from severe atopic dermatitis. The background includes subtle medical symbols like a stethoscope and molecular structures, emphasizing the scientific context of the treatment. The design is modern, clean, and optimistic.

Topline

Children with severe atopic dermatitis (AD) who often experience restricted growth can benefit from dupilumab treatment, which has been shown to improve their height significantly within 16 weeks.

Study Details

Atopic dermatitis (AD), a chronic inflammatory skin condition, not only impacts quality of life but also has systemic effects, including gr…

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.